Reasons to be cheerful: As we begin the year with the first edition of our Life Support quarterly sector note, the familiar ‘monument’ of the JP Morgan Healthcare conference provided the ‘deal-flow opener’ for January, setting in train a reasonable degree of optimism for the rest of 2025. Significant deals were announced from the very start of the conference week and highlighted the depth of interest in the life science sector and – hopefully – a better year against a somewhat subdued 2024. We d ....
